Insider trade

Amgen (AMGN): Officer had shares withheld for tax 1,616 shares

Derek Miller, Officer at Amgen, reported a tax withholding of 1,616 shares.

1,616
Shares · @ $366.21
Traded
Mar 16, 2026
Filed
Mar 19, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 16, 2026CongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
  2. Jan 29, 2026CongressDisclosed sale of AMGN — reported range $1,001 - $15,000
  3. Jan 30, 2026Company filing · Form 8-K · Agreement endedEnded an important agreement
  4. Feb 3, 2026Company filing · Form 8-K · ResultsReported its results
  5. Feb 17, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  6. Feb 19, 2026InsiderOfficer sold ~$376K of AMGN shares in the open market
  7. Feb 26, 2026Insider · 1 personInsiders: 2 sales (~$20.8M)
  8. Feb 26, 2026CongressDisclosed sale of AMGN — reported range $1,001 - $15,000
  9. Mar 9, 2026Government · Federal Register noticeGranting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
  10. Mar 9, 2026Government · Federal Register noticeAspen Global Inc. c/o Lachman Consultant Services, Inc., et al.; Withdrawal of Approval of 46 New Drug Applications

What came next

  1. Mar 24, 2026CongressDisclosed purchase of AMGN — reported range $15,001 - $50,000
  2. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  3. Mar 31, 2026Government · Federal Register proposed ruleFiduciary Duties in Selecting Designated Investment Alternatives
  4. Apr 17, 2026CongressDisclosed sale of AMGN — reported range $15,001 - $50,000
  5. Apr 22, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 22, 2026, Amgen Inc. (the “Company”) publicly announced that David M. Reese is retiring from the role of the Company’s Executive Vice President and Chief Technology Officer.”
  6. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  7. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
  8. Apr 30, 2026Government · Federal Register noticeChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing
  9. May 4, 2026InsiderOfficer sold ~$400K of AMGN shares in the open market
  10. May 14, 20265% stakeCapital World Investors reported a passive stake (13G) of 5.5%
  11. May 19, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 19, 2026, Amgen Inc. (the “Company”) publicly announced that Peter H. Griffith will retire from the role of the Company’s Executive Vice President and Chief Financial Officer, effective August 31, 2026.”
  12. Jun 4, 2026FDARecall: Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy. NDC 55513-810-60
  13. Jun 4, 2026FDARecall: Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC 55513-800-99), and b) 60 tablet bottles (NDC 55513-800-60), Rx Only, Amgen Inc., Th…
  14. Jun 4, 2026FDARecall: Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC…
  15. Jun 4, 2026FDARecall: Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC…
  16. Jun 4, 2026FDARecall: Sensipar (cinacalcet) Tablets, 30mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC…
  17. Jun 5, 2026CongressDisclosed purchase of AMGN — reported range $1,001 - $15,000
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Amgen

For Amgen, OQRO holds 6 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AMGN page.

Other recent filings by Derek Miller, SVP, Human Resources

The full history of Derek Miller, SVP, Human Resources is on the profile page.

How this filing works

Explore the data

Common questions

Which Amgen (AMGN) insider traded, and how much?

Derek Miller, Officer at Amgen, reported a tax withholding of 1,616 shares. At $366.21.

When did it happen, and when was it made public?

Traded: Mar 16, 2026. Filed: Mar 19, 2026. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Amgen recently?

For Amgen, OQRO holds 6 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the AMGN page.

Does this mean AMGN stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Amgen

Everything OQRO holds on this company is on its AMGN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data